The ongoing patent battle relating to Cefdinir polymorphism and crystalline forms is described from a scientific point of view. This case study illustrates some of the strategies adopted by generic bulk manufacturers to challenge originator's patents on polymorphic forms.
Cabri W, Ghetti P, Pozzi G, Alpegiani M (2007). Polymorphisms and patent, market, and legal battles: Cefdinir case study. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 11(1), 64-72 [10.1021/op0601060].
Polymorphisms and patent, market, and legal battles: Cefdinir case study
Cabri W;
2007
Abstract
The ongoing patent battle relating to Cefdinir polymorphism and crystalline forms is described from a scientific point of view. This case study illustrates some of the strategies adopted by generic bulk manufacturers to challenge originator's patents on polymorphic forms.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
